Tepnel Life Sciences - Joint Venture
December 21 1999 - 10:33AM
UK Regulatory
RNS Number:8964C
Tepnel Life Sciences PLC
21 December 1999
JOINT VENTURE WITH UNICS COMPLEMENTS TEPNEL'S SYSTEMS DEVELOPMENT
CAPABILITIES
Tepnel Life Sciences PLC ("Tepnel" or the "Company") announces that it
has extended its systems development capabilities by entering into a
commercial joint venture with Unics Automation PTE Ltd ("Unics"), the
Singapore-based product development and engineering group for
prototype development and final instrument manufacture. Unics is a
subsidiary of MMI Holdings Limited ("MMI"). MMI is listed on the Main
Board of the Stock Exchange of Singapore.
The commercial joint venture enables the two organisations to work
together in developing automated systems for third party companies in
the life science research, clinical diagnostics and food testing
markets.
Under the exclusive agreement, Tepnel will be responsible for the
sales and marketing activity and Unics will design, develop and
produce the instrumentation. The joint venture, (which excludes the
current DNA purification system and any other systems designed by
Tepnel), will involve profit sharing based upon the size, price and
commercial risk of each project.
Tepnel and Unics have already worked together very successfully on a
DNA purification system prototype which was designed and built by
Unics in only 10 weeks. This instrument, exhibited at the AACC
Exhibition (American Association for Clinical Chemistry) in New
Orleans in July 1999, received positive feedback from both end-users
and potential commercial partners. Unics provide Tepnel with the
engineering design, manufacturing skills and software capabilities it
requires to combine with its own DNA analysis expertise to develop
automated systems for the life science research, clinical diagnostics
and food testing markets. This partnering will be maintained for all
future Tepnel instrumentation projects.
Peter Raymond, Chairman and Acting CEO of Tepnel, said: "This
commercial venture enables Tepnel to offer a design and build
instrumentation service for the generation of sales and profits from
third party contracts, whilst consolidating the systems development
capabilities already created for future Tepnel instrumentation".
For further information, please contact:
Tepnel Life Sciences PLC Tel: 0161 445 9457
Peter Raymond, Chairman
Mike Billingham, Commercial Director
Rawlings Financial PR Limited Tel: 01904 621 914
Catriona Valentine
Notes to editors:
Established in 1993, Unics specialises in robotic systems integration,
cleanroom automation and the fabrication of precision handling and
assembly systems for 4 major industries ie biotech/life-sciences/
medical, electronics, data storage and defence. The company's 30,000
square feet facility houses a design group supported by CAD stations,
a tool-makers workshop, a tool assembly group and the core equipment
manufacturing and fabrication unit.
Unics is a subsidiary of MMI Holdings Limited, a mechanical systems
contract manufacturing and integration group. MMI is listed on the
Main Board of the Stock Exchange of Singapore, is a component stock of
the Straits Times 55 Index and has been granted Central Provident Fund
trustee stock status.
END
JVEFEDFIFUUUFFE
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024